Elephantiasis clinical trials
The registry lists 42 studies for Elephantiasis across more than 10 countries. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-04-02.
Status
- Completed
- 35
- Terminated
- 3
- Status unknown
- 2
- Not yet recruiting
- 1
- Withdrawn
- 1
Phase
- Phase 3
- 7
- Phase 2
- 7
- Phase 4
- 4
- Phase 1
- 2
Where
- Papua New Guinea
- 7
- India
- 6
- Ethiopia
- 4
- Mali
- 4
- United States
- 3
- Indonesia
- 3
Who runs them
Washington University School of Medicine (7) · National Institute of Allergy and Infectious Diseases (NIAID) (6) · University Hospitals Cleveland Medical Center (5) · London School of Hygiene and Tropical Medicine (4) · The Task Force for Global Health (3) · Lihir Medical Centre (2) · National Human Genome Research Institute (NHGRI) (2) · Noguchi Memorial Institute for Medical Research (2)
Studies
Recruiting first, then most recently updated. Showing 42 of 42 — search for more.
- Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health WorkersNot yet recruitingNCT07506967Not applicable5 countries
- East New Britain Province Monitoring & EvaluationCompletedNCT041242501 country
- Integrated Mapping of Skin-presenting Neglected Tropical Diseases in LiberiaCompletedNCT036837451 country
- Development of AWZ1066S, a Small Molecule Anti-Wolbachia Candidate Macrofilaricide DrugTerminatedNCT05084560Phase 11 country
- Evaluation and Characterisation of Microplastics and Nanoplastics in Joint Synovial LiquidStatus unknownNCT05678049
- Cluster RCT of Co-administration Azithromycin, Albendazole & IvermectinCompletedNCT03570814Phase 41 country
- Lymphatic Filariasis (LF) in Ivory CoastCompletedNCT02974049Not applicable1 country
- Adjunctive Ivermectin Mass Drug Administration for Malaria ControlStatus unknownNCT04844905Phase 31 country
- Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for LiberiaCompletedNCT019054361 country
- A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in MaliCompletedNCT02927496Phase 31 country
- A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in IndiaCompletedNCT02929121Phase 31 country
- A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in Sri LankaCompletedNCT02929134Phase 31 country
- Genetic and Other Aspects of PodoconiosisTerminatedNCT019394311 country
- Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in FijiCompletedNCT03177993Not applicable1 country
- Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic FilariasisCompletedNCT02899936Not applicable4 countries
- Prevalence Studies After Triple Drug Therapy for Lymphatic FilariasisCompletedNCT033522065 countries
- Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and OnchocerciasisCompletedNCT019054231 country
- Twice Yearly Treatment for the Control of LFCompletedNCT03036059Phase 41 country
- Promoting Consistent Shoe Use Among Children At High Risk for PodoconiosisCompletedNCT011605231 country
- Pharmacokinetics & Pharmacodynamics of Diethylcarbamazine (DEC)+ Albendazole (ALB) + Ivermectin (IVE)CompletedNCT02845713Phase 11 country
- Optimization of MDA With Existing Drug Regimens for LF: Monitoring Efficacy of Ongoing Treatment Programs in PNGCompletedNCT032682521 country
- Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )CompletedNCT03676140Phase 31 country
- PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs )CompletedNCT03664063Phase 21 country
- Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy StudyCompletedNCT02509481Phase 2/32 countries
- Prevalence of LF Infection in Districts Not Included in LF Control ActivitiesCompletedNCT031314011 country
- Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of AfricaCompletedNCT01975441Phase 21 country
- Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast)CompletedNCT020320431 country
- Effect of Albendazole Dose on Clearance of Filarial WormsCompletedNCT00375583Phase 21 country
- Effect of Albendazole Dose on Clearance of Filarial WormsCompletedNCT00339417Phase 21 country
- Doxycycline to Treat Mansonella Perstans Infection in Patients With and Without Lymphatic FilariasisCompletedNCT00340691Phase 21 country
- Medical Implications of Coinfection With Malaria and Filariasis ParasitesCompletedNCT004716661 country
- Exhaled NO Testing in FilariasisCompletedNCT016284971 country
- An RCT to Evaluate the Effect of a New Skin Care Regimen on SBF in Those With PodoconiosisCompletedNCT02839772Phase 3
- Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in MaliCompletedNCT02784743Phase 4
- Effect of Albendazole Dose on Treatment of Lymphatic FilariasisCompletedNCT00511004Phase 21 country
- Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in MalawiTerminatedNCT01213576Not applicable1 country
- Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic FilariasisWithdrawnNCT01903057Phase 41 country
- Disability and Quality of Life in Patients With Lymphatic Filariasis in Rural Southern IndiaCompletedNCT016297712 countries
- Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis EliminationCompletedNCT01586169Not applicable1 country
- Research for Elim of FilariasisCompletedNCT001452231 country
- Research for Elimination of Lymphatic Filariasis (ICIDR)CompletedNCT004066271 country
- Interaction Between HIV and Lymphatic FilariasisCompletedNCT00295698Not applicable